Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
This 2021 review explores the therapeutic potential of mesenchymal stem cell-derived exosomes (MSC-Exo) in treating neurocognitive disorders such as Alzheimer’s and Parkinson’s diseases. MSC-Exo are nano-sized extracellular vesicles enriched with neuroprotective and immunomodulatory molecules, including microRNAs, neural growth factors, and anti-inflammatory cytokines. These exosomes can cross the blood-brain barrier, attenuate
June 26, 2025
No Comments